Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity

Author:

Jarrad Angie M.ORCID,Ang Chee Wei,Debnath Anjan1,Hahn Hye Jee1,Woods Kyra2,Tan Lendl2,Sykes Melissa L.3,Jones Amy J.3,Pelingon Ruby,Butler Mark S.2ORCID,Avery Vicky M.3,West Nicholas P.2,Karoli TomislavORCID,Blaskovich Mark A. T.2ORCID,Cooper Matthew A.2ORCID

Affiliation:

1. Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States

2. Australian Infectious Diseases Research Centre, St. Lucia, Queensland 4067 Australia

3. Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia

Funder

National Center for Advancing Translational Sciences

National Health and Medical Research Council

Australian Research Council

Wellcome Trust

Queensland Government

Institute for Molecular Bioscience, University of Queensland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference59 articles.

1. Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases

2. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis

3. FDA Approves Symbiomix Therapeutics’ Solosec (Secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women. https://symbiomix.com/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/ (accessed Sep 1, 2018).

4. Benznidazole approved for Chagas disease in children

5. Estimating and Mapping the Population at Risk of Sleeping Sickness

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3